Side by side
Compare compounds
Add up to three compounds with the compare button on any library card or compound page.
Swipe the table sideways to see every compound.
| Attribute |  |
|---|---|
| Category | Metabolic |
| Evidence grade | A Human trial evidence |
| Regulatory status | Investigational |
| Human amounts | Trial dosesDosing reference Study durations |
| Format | Lyophilized vial |
| Type | Single compound |
| Molecular formula | Not listed |
| Molecular weight | Not listed |
| CAS number | Not listed |
| Sequence | Not listed |
| References | 11 |
| Summary | VK2735 is an investigational peptide that activates both the GLP-1 and GIP receptors and is being studied as a once-weekly injection and as an oral formulation. One 13-week phase 2 randomized trial has been published, and phase 3 trials are under way. It is not an approved medicine, and this entry is for research information only. |